High-Selectivity AMPA Receptor TAK-653

The state-of-the-art AMPA receptor positive allosteric modulator (PAM) TAK-653 (CAS 1211231-11-0) was created especially for cutting-edge neuroscience research. TAK-653 is distinguished from previous generations of AMPA potentiators by its tightly controlled, agonist-dependent activation, which improves natural neurotransmission without overstimulating the receptor in the absence of glutamate.

Identity: 1-(2-fluorophenyl)-N-(2-oxo-1,2-dihydroquinolin-6-yl)-5-oxopyrrolidine-3-carboxamide

Purity: ≥≥ 99.0% (HPLC Verified)

Form: White to off-white crystalline powder

Grade: Laboratory Research Grade

TAK-653's capacity to alter the glutamatergic system-the brain's principal excitatory pathway-is the key area of study.

1. Long-Term Potentiation (LTP), the biological foundation for learning and memory studies, is facilitated by synaptic plasticity.
2. BDNF Expression: It has been demonstrated to increase Brain-Derived Neurotrophic Factor (BDNF), a crucial protein for neurogenesis, in in vivo studies.
3. Rapid-Acting Modulator: Examined for its ability to cause neurobehavioral changes with a quick onset without the delay that comes with traditional antidepressants.

Because of its outstanding safety profile, TAK-653 stands out in the highly regulated US and European markets:

• High Safety Margin (Non-Convulsive): The potential to cause seizures is a significant disadvantage of many AMPA modulators. In contrast to its strong cognitive-enhancing benefits, TAK-653 has a broad therapeutic window and little convulsive potential. Risk-averse R&D institutions love it because of its "clean" character.
• Minimal Agonistic Activity: It avoids the "noise" of direct agonists by only functioning when natural glutamate is present.
• High-end B2B Supply: TIANJIN YINAO offers complete technical data packages (HPLC, NMR, LC-MS) that satisfy Western pharmaceutical labs' and CROs' strict quality audits.

• Glutamatergic Signaling And Synaptic Strength Are Studied In Experimental Neuroscience.
• Research On Cognitive Decline: Examining Ways To Prevent Age-Related Synapse Loss.
• Research On Fast-Acting Routes For Behavioral Outcomes Related To Mood Is Known As Mood Modulation Studies.
• Drug Discovery Scaffolds: A Reference Compound Used In The Creation Of Novel Neuroactive Compounds.

Feature	Gen 1: Idra-21 (Classic Foundation)	Gen 2: Sunifiram (High-Sensitivity)	Gen 3: TAK-653 (Precision Peak)
R&D Context	A classic Racetam derivative; the gold standard for AMPAR desensitization inhibitors.	A piperazine-based Ampakine structure known for its extreme potency.	Developed by Takeda; a clinical-grade, highly selective PAM.
Mechanism	Primarily slows down the desensitization process of the AMPA receptor.	Exhibits powerful AMPA receptor enhancement at micro-doses.	Agonist-dependent activation; only activates in the presence of natural glutamate.
Safety Margin	Narrow. Risk of over-excitation and neurotoxicity at high doses.	Moderate. High sensitivity requires extremely precise experimental dosing.	Extremely Broad. Virtually zero convulsive potential at research doses.
Research Value	The baseline reference standard for glutamatergic studies.	Ideal for studies requiring peak synaptic sensitivity and "potency."	The primary choice for institutions focusing on high-safety cognitive research.

TAK-653 addresses a persistent problem in the R&D market: excitotoxicity.

• Idra-21/Sunifiram: Their dose-response curves are usually "Bell-shaped," which means that beyond a certain dosage, the risk of overstimulation rises and safety sharply declines.
• Because of its "Agonist-dependent" mechanism, TAK-653's safety profile is described as a "Broad Safety Plateau." The receptor overload linked to earlier generations does not occur, even if the dose is raised within a research range.

Technical keywords: TAK-653 vs IDRA-21 safety profile, Sunifiram mechanism of action, Next-gen AMPA receptor PAMs wholesale.

Our products have successfully entered the global market and are widely used by internationally renowned brands in the pharmaceutical,health supplement, cosmetics, animal nutrition, and functional food industries. As a supplier with over 15 years of experience, our company offers approximately 2,000 plant extracts. We focus on core technology research and development, holding multiple invention patents and relying on a team of professors and industry experts to ensure the international competitiveness of our products under a rigorous quality certification system.

Higher standards, more reassuring protection

Hot Tags: high-selectivity ampa receptor tak-653, China high-selectivity ampa receptor tak-653 factory, amino tadalafil, resveratrol, β nicotinamide mononucleotide, spermidine 5, fasoracetam, d glucopyranoside